Unresectable vs. Resectable Thyroid Cancer (Pt. 1)

from Voices of Wisdom: A Podcast for Thyroid Clinicians · host TIRO, THANC Foundation

What makes a thyroid tumor truly unresectable? In this episode, Dr. Dana Hartl speaks with Dr. Mark Zafereo about how molecular testing and targeted neoadjuvant therapies are redefining surgical eligibility for patients with anaplastic thyroid cancer. Listen in as they explore the evolving role of BRAF/MEK inhibitors, imaging strategies, and real-world decision-making in complex cases.

Episode metadata supplied by the publisher feed · Published Jun 17, 2025

Embed this episode

Attribution link and audio player

What this episode covers

Can unresectable thyroid cancer become resectable? Dr. Zafereo shares insights on advanced therapies & surgical decision-making.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Unresectable vs. Resectable Thyroid Cancer (Pt. 1)

0:00 27:13

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Voices of Wisdom: A Podcast for Thyroid Clinicians?

This episode is 27 minutes long.

When was this Voices of Wisdom: A Podcast for Thyroid Clinicians episode published?

This episode was published on June 17, 2025.

Is there a transcript available for this episode?

Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.

Can I download this Voices of Wisdom: A Podcast for Thyroid Clinicians episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!